Volume 21, Issue 6, Pages (June 2014)

Slides:



Advertisements
Similar presentations
John Hines, Michael Groll, Margaret Fahnestock, Craig M. Crews 
Advertisements

Rational Design of Combination Enzyme Therapy for Celiac Sprue
Multimodal Assessment of Estrogen Receptor mRNA Profiles to Quantify Estrogen Pathway Activity in Breast Tumors  Anita Muthukaruppan, Annette Lasham,
Volume 18, Issue 10, Pages (October 2011)
Scratch n’ Screen for Inhibitors of Cell Migration
Volume 20, Issue 4, Pages (April 2013)
Volume 18, Issue 11, Pages (November 2011)
Light-Mediated Inhibition of Protein Synthesis
Volume 22, Issue 12, Pages (December 2015)
Jacqueline L. Blankman, Gabriel M. Simon, Benjamin F. Cravatt 
SAGA Is a General Cofactor for RNA Polymerase II Transcription
Volume 18, Issue 10, Pages (October 2011)
Volume 21, Issue 11, Pages (November 2014)
Rational Design of Combination Enzyme Therapy for Celiac Sprue
Human Senataxin Resolves RNA/DNA Hybrids Formed at Transcriptional Pause Sites to Promote Xrn2-Dependent Termination  Konstantina Skourti-Stathaki, Nicholas J.
Volume 29, Issue 2, Pages (February 2008)
John Hines, Michael Groll, Margaret Fahnestock, Craig M. Crews 
Highly Efficient Self-Replicating RNA Enzymes
Volume 19, Issue 7, Pages (July 2012)
PMI: A ΔΨm Independent Pharmacological Regulator of Mitophagy
Volume 13, Issue 8, Pages (November 2015)
Volume 19, Issue 8, Pages (August 2012)
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Molecular Organization of Drosophila Neuroendocrine Cells by Dimmed
Structure-Guided Design of Fluorescent S-Adenosylmethionine Analogs for a High- Throughput Screen to Target SAM-I Riboswitch RNAs  Scott F. Hickey, Ming C.
Volume 26, Issue 1, Pages (January 2016)
Cell-Type-Specific Control of Enhancer Activity by H3K9 Trimethylation
Volume 18, Issue 11, Pages (November 2011)
Volume 19, Issue 6, Pages (June 2012)
Fluorogenic Probe for Constitutive Cellular Endocytosis
The Efficacy of siRNAs against Hepatitis C Virus Is Strongly Influenced by Structure and Target Site Accessibility  Selena M. Sagan, Neda Nasheri, Christian.
Volume 19, Issue 3, Pages (August 2005)
Volume 25, Issue 3, Pages e3 (March 2018)
Volume 19, Issue 12, Pages (December 2012)
SUMO-2 Orchestrates Chromatin Modifiers in Response to DNA Damage
Volume 19, Issue 7, Pages (July 2012)
Volume 16, Issue 12, Pages (December 2009)
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
The Timing of Midzone Stabilization during Cytokinesis Depends on Myosin II Activity and an Interaction between INCENP and Actin  Jennifer Landino, Ryoma.
Volume 19, Issue 2, Pages (February 2012)
Volume 30, Issue 4, Pages (May 2008)
Volume 15, Issue 1, Pages 5-11 (January 2008)
Characterization of Monoacylglycerol Lipase Inhibition Reveals Differences in Central and Peripheral Endocannabinoid Metabolism  Jonathan Z. Long, Daniel.
SUMO-2 Orchestrates Chromatin Modifiers in Response to DNA Damage
Volume 17, Issue 1, Pages (January 2010)
Volume 14, Issue 8, Pages (August 2007)
Volume 21, Issue 11, Pages (November 2014)
Inhibitor Mediated Protein Degradation
Control of Centriole Length by CPAP and CP110
Volume 26, Issue 6, Pages (June 2007)
Volume 17, Issue 12, Pages (December 2010)
Sara K. Donnelly, Ina Weisswange, Markus Zettl, Michael Way 
UA62784 Is a Cytotoxic Inhibitor of Microtubules, not CENP-E
Volume 19, Issue 3, Pages (August 2005)
Volume 21, Issue 22, Pages (November 2011)
Volume 14, Issue 10, Pages (October 2007)
Volume 13, Issue 6, Pages (June 2006)
Volume 12, Issue 6, Pages (June 2005)
Analyzing Fission Yeast Multidrug Resistance Mechanisms to Develop a Genetically Tractable Model System for Chemical Biology  Shigehiro A. Kawashima,
Volume 16, Issue 7, Pages (July 2009)
Volume 24, Issue 1, Pages (January 2017)
Volume 21, Issue 9, Pages (September 2014)
Volume 18, Issue 11, Pages (November 2011)
Volume 13, Issue 11, Pages (November 2006)
Volume 17, Issue 5, Pages (May 2010)
Small, Mobile FcɛRI Receptor Aggregates Are Signaling Competent
Volume 17, Issue 8, Pages (August 2010)
Volume 22, Issue 12, Pages (December 2015)
Michael U. Shiloh, Paolo Manzanillo, Jeffery S. Cox 
Volume 21, Issue 9, Pages (September 2014)
Presentation transcript:

Volume 21, Issue 6, Pages 743-753 (June 2014) Defining Estrogenic Mechanisms of Bisphenol A Analogs through High Throughput Microscopy-Based Contextual Assays  Fabio Stossi, Michael J. Bolt, Felicity J. Ashcroft, Jane E. Lamerdin, Jonathan S. Melnick, Reid T. Powell, Radhika D. Dandekar, Maureen G. Mancini, Cheryl L. Walker, John K. Westwick, Michael A. Mancini  Chemistry & Biology  Volume 21, Issue 6, Pages 743-753 (June 2014) DOI: 10.1016/j.chembiol.2014.03.013 Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 1 Comparison of GFP-ERβ:PRL-HeLa versus GFP-ERα:PRL-HeLa Stable Cell Lines (A) Experimental workflow for BPX analysis. (B) PRL-HeLa array cells (ERα in red and ERβ in blue) were treated with 10 nM E2 for the indicated times, and the percentage of cells with an array was measured. (C–E) Six-point dose-response analysis for the percentage arrays measurement at the 30 min time point for E2 (C), 4-OHT (D), and raloxifene (E). (F) Six-point dose-response analysis for the array area measurement (in pixels) after 30 min of E2 treatment. (G–I) Recruitment of SRC-1 (G), SRC-2 (H), and SRC-3 (I) to the array after 30 min of E2 and 4OHT treatment measured as loading (Bolt et al., 2013). ∗p < 0.05 between ERα and ERβ. (J) Serine 5 phosphorylated RNA polymerase II loading to the array after 30 min of E2 treatment (six-point dose-response analysis). (K) dsRED2 RNA FISH time-course analysis after E2 treatment represented as intensity at the array normalized to vehicle treatment, which was set as 1. Error bars represent standard deviation from three to five independent experiments. Chemistry & Biology 2014 21, 743-753DOI: (10.1016/j.chembiol.2014.03.013) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 2 HT Microscopy Platforms Define ERα versus ERβ Selectivity of BPXs (A) LogEC50 values were calculated after six-point dose-response analysis using either a PCA or the PRL array stable cell lines. In the heatmap, red indicates high-activity compounds, while blue indicates low-activity compounds. (B–E) Examples of dose-response curves for four BPXs comparing PCA and PRL array platforms. Error bars represent standard deviation from three to five independent experiments. Chemistry & Biology 2014 21, 743-753DOI: (10.1016/j.chembiol.2014.03.013) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 3 Analysis of Efficacy and Chromatin-Remodeling Potential of BPXs Percentage of cells with an array (A) or array area (B) was measured at the maximal BPX dose (10 μM) after 30 min of treatment of GFP-ERα:PRL-HeLa and GFP-ERβ:PRL-HeLa cells. Heatmaps were generated after normalizing the data to E2, which was set as 1. Error bars represent standard deviation from three to five independent experiments. Chemistry & Biology 2014 21, 743-753DOI: (10.1016/j.chembiol.2014.03.013) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 4 Transcriptional Response to BPXs in PRL Array Cell Lines (A and B) dsRED2 RNA FISH intensity at the array after 30 min of BPX 10 μM (A) or BPX + E2 10 nM (B) in GFP-ERα:PRL-HeLa (gray bars) or GFP-ERβ:PRL-HeLa (black bars) cells. Veh = vehicle. Error bars represent standard deviation from 3 independent experiments. (C and D) Venn diagrams representing the different categories of responses by BPXs in ERα-containing (C) or ERβ-containing (D) cells. See text for further description of the categories. Chemistry & Biology 2014 21, 743-753DOI: (10.1016/j.chembiol.2014.03.013) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 5 Effect of BPXs on Endogenous ERα Activity in MCF-7 Breast Cancer Cells (A) MCF-7 cells were treated for 24 hr with BPXs (10 μM, gray bars) or BPX + E2 10 nM (black bars) and then labeled with ERα antibody. Nuclear ER intensity was then quantified. Data are represented as relative to vehicle control. (B) MCF-7 cells were treated for 24 hr with BPXs (10 μM, gray bars) or BPX+E2 10 nM (black bars) and then hybridized with GREB1 intron mRNA FISH probes. Data indicate the average number of transcriptionally active foci per cell after setting vehicle treatment at 1. Error bars represent standard deviation from three independent experiments. Chemistry & Biology 2014 21, 743-753DOI: (10.1016/j.chembiol.2014.03.013) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 6 Clustering Analysis of BPXs’ Activity across All HT Microscopy Assays Performed Data in each assay row were range normalized before clustering analysis. Clustering was performed using Euclidean distance for both the compounds and the assays. Chemistry & Biology 2014 21, 743-753DOI: (10.1016/j.chembiol.2014.03.013) Copyright © 2014 Elsevier Ltd Terms and Conditions